Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

August 1, 2021; Volume 62,Issue 8
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Lahoutte, Tony

    1. Phase I Trial of <sup>131</sup>I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients
      You have access
      Phase I Trial of 131I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients
      Matthias D’Huyvetter, Jens De Vos, Vicky Caveliers, Ilse Vaneycken, Johannes Heemskerk, Francois P. Duhoux, Christel Fontaine, Marian Vanhoeij, Albert D. Windhorst, Frank van der Aa, N. Harry Hendrikse, Jos L.E. Eersels, Hendrik Everaert, Pieterjan Gykiere, Nick Devoogdt, Geert Raes, Tony Lahoutte and Marleen Keyaerts
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1097-1105; DOI: https://doi.org/10.2967/jnumed.120.255679
  2. Langer, Oliver

    1. You have access
      Repurposing 99mTc-Mebrofenin as a Probe for Molecular Imaging of Hepatocyte Transporters
      Solène Marie, Irene Hernández-Lozano, Oliver Langer and Nicolas Tournier
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1043-1047; DOI: https://doi.org/10.2967/jnumed.120.261321
  3. Larson, Steve

    1. You have access
      Overview of the First NRG Oncology–National Cancer Institute Workshop on Dosimetry of Systemic Radiopharmaceutical Therapy
      Emilie Roncali, Jacek Capala, Stanley H. Benedict, Gamal Akabani, Bryan Bednarz, Vikram Bhadrasain, Wesley E. Bolch, Jeffrey C. Buchsbaum, Norman C. Coleman, Yuni K. Dewaraja, Eric Frey, Michael Ghaly, Joseph Grudzinski, Robert F. Hobbs, Roger W. Howell, John L. Humm, Charles A. Kunos, Steve Larson, Frank I. Lin, Mark Madsen, Saed Mirzadeh, David Morse, Daniel Pryma, George Sgouros, Sara St. James, Richard L. Wahl, Ying Xiao, Pat Zanzonico and Katherine Zukotynski
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1133-1139; DOI: https://doi.org/10.2967/jnumed.120.255547
  4. Larson, Steven

    1. Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with <sup>18</sup>F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort Study
      You have access
      Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with 18F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort Study
      Andreas G. Wibmer, Michael J. Morris, Mithat Gonen, Junting Zheng, Hedvig Hricak, Steven Larson, Howard I. Scher and Hebert Alberto Vargas
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1050-1056; DOI: https://doi.org/10.2967/jnumed.120.256602
  5. Lassen, Martin Lyngby

    1. Simulation of Low-Dose Protocols for Myocardial Perfusion <sup>82</sup>Rb Imaging
      You have access
      Simulation of Low-Dose Protocols for Myocardial Perfusion 82Rb Imaging
      Martin Lyngby Lassen, Yuka Otaki, Paul Kavanagh, Robert J.H. Miller, Daniel S. Berman and Piotr J. Slomka
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1112-1117; DOI: https://doi.org/10.2967/jnumed.120.252429
  6. Leach, Benjamin I.

    1. Metallofluorocarbon Nanoemulsion for Inflammatory Macrophage Detection via PET and MRI
      You have access
      Metallofluorocarbon Nanoemulsion for Inflammatory Macrophage Detection via PET and MRI
      Chao Wang, Benjamin I. Leach, Deanne Lister, Stephen R. Adams, Hongyan Xu, Carl Hoh, Patrick McConville, Jing Zhang, Karen Messer and Eric T. Ahrens
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1146-1153; DOI: https://doi.org/10.2967/jnumed.120.255273
  7. Lee, Hsiaoju

    1. Kinetic Modeling of <sup>18</sup>F-(2<em>S,</em>4<em>R</em>)4-Fluoroglutamine in Mouse Models of Breast Cancer to Estimate Glutamine Pool Size as an Indicator of Tumor Glutamine Metabolism
      You have access
      Kinetic Modeling of 18F-(2S,4R)4-Fluoroglutamine in Mouse Models of Breast Cancer to Estimate Glutamine Pool Size as an Indicator of Tumor Glutamine Metabolism
      Varsha Viswanath, Rong Zhou, Hsiaoju Lee, Shihong Li, Abigail Cragin, Robert K. Doot, David A. Mankoff and Austin R. Pantel
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1154-1162; DOI: https://doi.org/10.2967/jnumed.120.250977
  8. Lehnert, Wencke

    1. Evaluation of Safety and Dosimetry of <sup>177</sup>Lu-DOTA-ZOL for Therapy of Bone Metastases
      Open Access
      Evaluation of Safety and Dosimetry of 177Lu-DOTA-ZOL for Therapy of Bone Metastases
      René Fernández, Elisabeth Eppard, Wencke Lehnert, Luis David Jiménez-Franco, Cristian Soza-Ried, Matías Ceballos, Jessica Ribbeck, Andreas Kluge, Frank Rösch, Marian Meckel, Konstantin Zhernosekov, Vasko Kramer and Horacio Amaral
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1126-1132; DOI: https://doi.org/10.2967/jnumed.120.255851
  9. Li, Shihong

    1. Kinetic Modeling of <sup>18</sup>F-(2<em>S,</em>4<em>R</em>)4-Fluoroglutamine in Mouse Models of Breast Cancer to Estimate Glutamine Pool Size as an Indicator of Tumor Glutamine Metabolism
      You have access
      Kinetic Modeling of 18F-(2S,4R)4-Fluoroglutamine in Mouse Models of Breast Cancer to Estimate Glutamine Pool Size as an Indicator of Tumor Glutamine Metabolism
      Varsha Viswanath, Rong Zhou, Hsiaoju Lee, Shihong Li, Abigail Cragin, Robert K. Doot, David A. Mankoff and Austin R. Pantel
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1154-1162; DOI: https://doi.org/10.2967/jnumed.120.250977
  10. Lin, Frank I.

    1. You have access
      Imaging of Pheochromocytoma and Paraganglioma
      Jorge A. Carrasquillo, Clara C. Chen, Abhishek Jha, Alexander Ling, Frank I. Lin, Daniel A. Pryma and Karel Pacak
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1033-1042; DOI: https://doi.org/10.2967/jnumed.120.259689
    2. You have access
      Overview of the First NRG Oncology–National Cancer Institute Workshop on Dosimetry of Systemic Radiopharmaceutical Therapy
      Emilie Roncali, Jacek Capala, Stanley H. Benedict, Gamal Akabani, Bryan Bednarz, Vikram Bhadrasain, Wesley E. Bolch, Jeffrey C. Buchsbaum, Norman C. Coleman, Yuni K. Dewaraja, Eric Frey, Michael Ghaly, Joseph Grudzinski, Robert F. Hobbs, Roger W. Howell, John L. Humm, Charles A. Kunos, Steve Larson, Frank I. Lin, Mark Madsen, Saed Mirzadeh, David Morse, Daniel Pryma, George Sgouros, Sara St. James, Richard L. Wahl, Ying Xiao, Pat Zanzonico and Katherine Zukotynski
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1133-1139; DOI: https://doi.org/10.2967/jnumed.120.255547
« Previous (Pages : 1 2 ... 2) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 62 (8)
Journal of Nuclear Medicine
Vol. 62, Issue 8
August 1, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • Synthesis and Evaluation of 18F-Enzalutamide, a New Radioligand for PET Imaging of Androgen Receptors: A Comparison with 16β-18F-Fluoro-5α-Dihydrotestosterone
  • Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on 18F-Fluciclovine PET/CT Guidance
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire